Contribute Try STAT+ Today

After seven years of sparring, Novartis (NVS) has agreed to pay $678 million to settle a lawsuit in which the federal government alleged the drug maker used kickbacks to doctors — including fishing trips and lavish restaurant meals — in order to boost prescriptions of several medicines.

The settlement ends a long-running battle that began in 2011, when a former Novartis sales rep named Oswald Bilotta filed a whistleblower lawsuit claiming the company ran so-called speaker programs that were actually blatant marketing tools, rather than educational sessions for doctors. And as a result of the bribes, the drug maker caused federal health care programs to overpay for medicines.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.